Successful treatment of linear immunoglobulin A bullous dermatosis with dupilumab in a pediatric patient
Main Authors: | Nouf Almuhanna, MD, Rasha Alhamazani, MD, Sarah Alkhezzi, MD, Mahdi T. Alfataih, MD, Salman Al-Malki, MD, Anwar R. Alrashidi, MD, Faris A. Alhomida, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-08-01
|
Series: | JAAD Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512623001923 |
Similar Items
-
Assessing the use of dupilumab in a pediatric patient with bullous congenital ichthyosiform erythroderma
by: Nouf Almuhanna, MD, et al.
Published: (2023-09-01) -
Recalcitrant bullous pemphigoid responsive to dupilumab in an adolescent patient
by: Albert E. Zhou, MD, PhD, et al.
Published: (2022-11-01) -
Dupilumab in acquired perforating dermatosis: A potential new treatment
by: Musaed M. Alsebayel, MD, et al.
Published: (2022-10-01) -
Letter in reply: Linear IgA bullous dermatosis treated with dupilumab in a pediatric patient with glucose-6-phosphate dehydrogenase deficiency
by: Sonal Muzumdar, MD, et al.
Published: (2024-02-01) -
Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid
by: Yihua Zhang, et al.
Published: (2021-10-01)